Is Carysil overvalued or undervalued?

As of 14 August 2025, Carysil's valuation grade has moved from fair to expensive, indicating that the company is currently overvalued. The key ratios reflect this assessment, with a PE Ratio of 33.14, an EV to EBITDA of 17.57, and a PEG Ratio of 4.53, all suggesting a premium valuation relative to its earnings growth potential.
In comparison to its peers, Carysil's PE Ratio is notably high, especially when compared to L T Foods, which has a PE of 24.92 and is rated very attractive, and Cera Sanitary, which has a PE of 33.55 and is rated attractive. This indicates that Carysil may not justify its current price relative to its earnings when compared to these competitors. Additionally, while Carysil has outperformed the Sensex in the short term with a 1-week return of 2.76% versus -0.03% for the Sensex, its long-term performance shows a significant disparity, with a 5-year return of 800.71% compared to the Sensex's 112.79%. Overall, Carysil appears to be overvalued at its current price of 823.70.